IKT-001 — Interim data
Mid 2028
Unblinded PVR Reduction Readout for Part A of IMPROVE-PAH Mid 2028 Type C Meeting Request Filed with FDA to Support Immediate Transition (n=120) ✓Source filing
IKT biotech catalysts & pipeline
INHIBIKASE THERAPEUTICS INC · Data as of 2026-09-08